HOXA9 and ovarian cancer: Previous studies showed that BMPER, CXCL10, and HOXA9 promote tumor angiogenesis and tumorigenesis in lung cancer, colon cancer, basal cell carcinoma, ovarian cancer, and liver tumor (35–38).